Abstract
Natural products containing cannabinoids derived from Cannabis sativa (L.), a medicinal plant with a long history of ethnobotanical uses, are now emerging as popular dietary supplements in the consumer marketplace. In spite of the ambiguous interpretation of the federal legal status, cannabinoid products are now readily available from online outlets and are increasingly being marketed by mainstream retailers. Many states have enacted legislation conferring various levels of legal status to Cannabis, and in recent months thirteen states have passed so called "low-THC" or "CBD-only" laws to allow widespread access to certain natural products that are less contentious in terms of the current Schedule I classification by the federal Controlled Substances Act. Although techniques exist for quantification of cannabinoids in crude plant materials as well as in blood and urine, dietary supplements present analytical challenges due to complex matrices and the inherent variability of bioactive forms with oral delivery. Reported here is a validated method for rapid determination of cannabidiol (CBD), cannabidiolic acid (CBD-A), Δ9-tetrahydrocannabinol (THC), Δ9-tetrahydrocannabinolic acid (THC-A) and cannabigerol using UPLC with detection by photo-diode array and single quadrupole mass spectrometry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
